INTRODUCTION
============

The subclavian steal syndrome (SSS) is characterized by the vertebral artery flow inversion, due to a stenotic lesion in the origin of the subclavian artery. The Coronary-subclavian Steal Syndrome is a variation of the SSS and is characterized by inversion of flow in the Internal Mammary artery that has been used as conduct in a myocardial revascularization, leading to miocardial infarction.

Its diagnosis must be suspected in patients with difference in pulse and arterial pressure in the upper limbs, that present with angina pectoris and that have done a myocardial revascularization.

Its treatment must be a surgical bypass or, after the rise of the minimal invasive techniques, a transluminal angioplasty.

Objective
---------

The objective of this article is to show the left subclavian artery stenting as a safe and effective method to treat the Coronary-subclavian Steal Syndrome.

METHODS
=======

Retrospective, non-randomized trial, through revision of the hospital records of the patients treated with the stenting of the left subclavian artery, from January 2006 to September 2012. Epidemiological and clinical data were assessed, as well as technique and materials used in the procedure. The study was approved by the ethics commission.

The procedures were performed after local anesthesia and positioning of a valvulated sheath in the common right femoral artery and in the left brachial artery, by the Seldinger technique. After systemic heparin, the lesion was crossed with a 0.035\'\' hydrophilic guidewire, and then it was exchanged by a stiff wire of the same diameter, to give support to the stent ([Figure 1](#f01){ref-type="fig"}). This approach allows several attempts of recanalization, whether proximal or distal to the lesion and appropriate angiographic control ([Figure 2](#f02){ref-type="fig"}).

![Filling of the left subclavian artery by retrograde flow of the left internal mammary artery](rbccv-29-02-0236-g01){#f01}

![Proximal and distal access to the lesion access and facilitating overtaking angiographic control](rbccv-29-02-0236-g02){#f02}

Balloon expandable stents were used in the majority of the cases; only one selfexpandable stent was used. The sizes varied form 7 to 10 mm in diameter and 25 to 60 mm in length. The material selection was made by visual angiographic analysis and was based on the nominal diameter of the target vessel, diameter proximal and distal to the lesion and the extension of it ([Figure 3](#f03){ref-type="fig"}). Only one of the four cases of occlusion demanded pre dilatation ([Figure 4](#f04){ref-type="fig"}), due to the difficulty of moving the balloon expandable stent through the lesion.

![Balloon Expandable stent being released by brachial access](rbccv-29-02-0236-g03){#f03}

![Filling anterograde left subclavian artery and the proximal third of the left internal thoracic artery](rbccv-29-02-0236-g04){#f04}

All patients were receiving antiplatelet therapy with acetylsalicylic acid (ASA) at the time of diagnosis, in doses ranging from 75 to 325 mg/day. In addition, Clopidogrel was started 75 mg/day orally, or 300 mg loading dose in the morning of the procedure, maintaining the dual antiplatelet therapy for 30 days.

The monitoring was carried out on an outpatient basis and by performing ultrasound duplex color of the left subclavian artery. Routinely the patient returned to the Endovascular clinic in a week for initial evaluation of pulse and pressure measurement in the upper limbs. Then we continued monitoring in the sector of origin.

RESULTS
=======

Four thousand two hundred and ninety one coronary artery bypasses were performed in this period with the use of the left internal mammary artery angioplasty and 69 angioplasties of the subclavian artery in this Institute, identifying 16 patients with the Coronary-subclavian steal syndrome (CSSS). All of them underwent endovascular treatment.

The mean age of patients was 67.2 (53-81 years), sevenfemales and nine males. [Table 1](#t01){ref-type="table"} shows the distribution of risk factors among patients treated. The clinical presentation leading to diagnosis of CSSS varied, and three patients presented with acute myocardial ischemia and in the other 12, the diagnosis was made by coronary angiography after provocative test positive for ischemia. In only one case the diagnosis was made after coronary angiography prior to percutaneous valve replacement ([Table 2](#t02){ref-type="table"}). Of the 16 patients included, 13 had stenoses and three had occlusions, in all cases in the proximal left subclavian artery.

###### 

Demographical Characteristics of the analyzed patients.

  n                                                                 16
  ----------------------------------------------------------------- --------------------
  Age                                                               67.2 (53-83 years)
  Male                                                              9 (56.2%)
  Female                                                            7 (43.7%)
  Systemic Hypertension                                             16 (100%)
  Diabetes Mellitus                                                 7 (43.7%)
  Dyslipidemia                                                      13 (81.2%)
  Smoking                                                           5 (31.2%)
  • Former smokers                                                  7 (43.7%)
  Chronic Renal Insufficiency[\*](#tfn01t03){ref-type="table-fn"}   1 (6.2%)

Non dialysis chronic renal insufficiency patient, being treated after adequate renal preparation

###### 

Clinical characteristics of the patients.

  Acute Myocardial Infarction                  3 (18.7%)
  -------------------------------------------- -----------
  Angina/Positive provocative test             12 (75%)
  Others[\*](#tfn01t02){ref-type="table-fn"}   1 (6.2%)

Asymptomatic patient; diagnosis in the coronary angiography previous to valve replacement surgery

The therapeutic success rate was 100%, with the criterion of antegrade flow in the internal mammary through digital angiography. Two patients experienced minor complications, being a minor hematoma and pseudoaneurysm that did not require surgical correction. No patient had major complications. Upon examination of the medical records, 11 patients had sonographic documentation of stent patency for at least one year; two patients lost follow-up and two died. One of infection and sepsis in diabetic foot and other unknown cause. In all cases there was clinical improvement of symptoms after the procedure.

DISCUSSION
==========

With an incidence between 0.5% and 2% of patients undergoing coronary artery bypass grafting^\[[@r01]\]^, the CSSS was initially described by Hargola / Valle and Tyras / Barner in the 70s, concurrently with the beginning of the use of the internal mammary artery as a conduit artery^\[[@r02]\]^. The use of this artery is widely accepted because of its high long-term patency rate and low atherosclerosis, being used in most Coronary artery bypasses^\[[@r03]-[@r06]\]^. The incidence of this syndrome was 0.3% in our study, being equivalent to that found in the literature. All cases diagnosed underwent endovascular treatment.

The left subclavian artery is the branch of the aortic arch most affected by atherosclerosis^\[[@r07]\]^, which is the main cause of the syndrome. This also explains why the vast majority of cases in the literature CSSS occur on the left side, not being different in the cases presented. Other causes include Takayasu arteritis, actinic arteritis and giant cell arteritis^\[[@r01]\]^. The occlusion of the proximal subclavian artery causes flow reversal in arteries downstream (vertebral and internal mammary), leading to several vertebral- basilary symptoms (dizziness, nystagmus, nausea) and myocardial ischemia^\[[@r02]\]^.

Conventional surgical revascularization procedures have good long-term patency^\[[@r07]\]^, but contain a risk of morbidity of 4-11% and a mortality rate of up to 5%. Options include subclavian-subclavian, carotid-subclavian, axillary- axillary grafts, subclavian- carotid transposition or even transposition of the internal mammary artery. Potential complications include fistula of the thoracic duct, Horner\'s syndrome, supraclavicular nerve injury (eg N. Phrenic and recurrent laryngeal) and decompensation of preexisting atherosclerotic disease in the supra-aortic trunks, thereby leading to ischemic or neurological symptoms^\[[@r07],[@r08]\]^.

In the cases presented, there were two minor complications and no major complications, besides the therapeutic and clinical success of 100%. The technical literature reports success of more than 80%, with rates of complications from 3 to 6% and high patency up to ten years of follow-up^\[[@r05],[@r07],[@r09],[@r10]\]^. None of the patients experienced vertebrobasilar acute neurological symptoms due to reverse flow in vertebral artery, which protects cerebral circulation leading to embolic events fragments plate to the upper member. The forward flow is restored gradually from 20 seconds to 30 minutes, probably due systems of cerebral selfregulation by decreasing vascular resistance^\[[@r03],[@r08]\]^. There are reports in the literature of internal mammary artery blockage and aspiration of blood through the brachial catheter during the procedure, to avoid potential embolization to coronary territory, especially when it is noted an antegrade flow in the internal mammary - a variant of the CSSS^\[[@r03],[@r10]\]^. However, in the patients presented, this technique was not used, without any harm to the result.

The choice of balloon expandable stents rather than selfexpandable in most cases is due to its greater radial strength and greater accuracy in delivery. However, in very tight lesions or occlusions when it perceives a certain resistance in the positioning of the stent, may be necessary pre-dilation to facilitate their passage and to prevent it from deforming over the balloon. In the cases presented, only one required a pre-dilatation.

One should remember that the label of the balloon- expandable stents available on the market today does not include its use in the supra -aortic area. The use of these stents in this region is due to the excellent results in case series.

In most services is not routine an angiographic study of aortic arch and supra-aortic trunks prior to Coronary artery bypass^\[[@r07],[@r11]\]^. Thus, the physical examination of the upper limbs is necessary, so you can detect any change in pulse/pressure or supraclavicular souffle before surgery^\[[@r05],[@r12]\]^. In contrast, in revascularized patients presenting with acute or insidious myocardial ischemia, we must always remember the CSSS as a possible etiology. In fact, the development of this syndrome in less than a year after myocardial revascularization suggests the presence of subclavian steal syndrome not diagnosed by the time of surgery^\[[@r05]\]^.

CONCLUSION
==========

Angioplasty and stenting of the left subclavian artery is a good option for the treatment of coronary subclavian steal syndrome, with high rates of technical and clinical success. Besides, does not preclude surgical treatment, in the case of more than one unsuccessfull endovascular attempt.
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